Latest Articles

In this article, we look to the technologies and innovations that will define the future of science.

My Green Lab's mission is to build a culture of sustainability in science. In this interview with CEO James Connelly, we find out how the non-profit is striving to achieve this goal.

Sophie Prosolek explores why some vaccines last a lifetime, while others do not, for Technology Networks.

In this article, we explore atomic absorption spectroscopy, what is is, how it works, strengths and limitations and the areas in which the technique finds utility.

In this article, we will compare the two key drug discovery approaches, the challenges and opportunities of each and the future of target-based drug discovery.

Most vaccine development begins with looking at the pathogen. Scientists pinpoint key residues needed for the virus to enter the body and develop vaccines that train the body to recognize signatures of the foreign invader. Kevin O'Neil Saunders, associate professor of surgery and director of research at the Duke Human Vaccine Institute at Duke University develops vaccines after analyzing the body’s immune response to a pathogen.

Various biopharmaceutical analysis techniques are used to gain vital insights into the composition, quality, stability and safety of complex biotherapeutics throughout the development pipeline. In this article, we take a closer look at some of the strategies employed by scientists in the field.

Investment in vaccine science and technology development can provide us with the tools to respond to pathogens with pandemic potential. In this opinion article, Ariana Gomes discusses the use of AI for creating universal vaccines.

This article will highlight how new pipetting systems are helping scientists achieve more reliable and reproducible datasets, and discuss how manufacturers are supporting customers to get the most from pipetting systems.

Cold-chain distribution requirements complicate vaccine access, reducing vaccination rates for life-threatening, but preventable diseases. Now, researchers have developed a portable production platform for shelf-stable, antibacterial vaccines.